Out of context: Clinical practice guidelines and patients with multiple chronic conditions a systematic review

Medical Care

Volumn 52, Issue 3 SUPPL. 2, 2014, Pages

  Wyatt, Kirk D ^a,b   Stuart, Louise M ^a,c   Brito, Juan P ^a,d   Leon, Barbara Carranza ^a,d   Domecq, Juan Pablo ^a   Prutsky, Gabriela J ^a   Egginton, Jason S ^e   Calvin, Andrew D ^a   Shah, Nilay D ^e   Murad, Mohammad Hassan ^a   Montori, Victor M ^d  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Division of Endocrinology   (United States)

^e Health Care Policy and Research   (United States)

Author keywords

Comorbidities; Diabetes; Diabetes mellitus; Minimally disruptive medicine; Shared decision making

Indexed keywords

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; PATIENT-CENTERED CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 84894450960     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3182a51b3d     Document Type: Article

References (64)

1. Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-332. (Pubitemid 40293405)
2. Centers for Disease Control. National Diabetes Fact Sheet. 2007. Available at: http://www.cdc.gov/diabetes/pubs/estimates07.htm. Accessed March 29, 2010.
3. May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009;339:b2803.
4. Shippee ND, Shah ND, May CR, et al. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65:1041-1051.
5. Vijan S, Hayward RA, Ronis DL, et al. Brief report: the burden of diabetes therapy: implications for the design of effective patientcentered treatment regimens. J Gen Intern Med. 2005;20:479-482. (Pubitemid 40980453)
6. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of diseasespecific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870-2874.
7. National Quality Forum. Multiple chronic conditions measurement framework. 2012. Available at: http://www.qualityforum.org/Publications/2012/05/ MCC-Measurement-Framework-Final-Report.aspx. Accessed March 23, 2013.
8. World Health Organization. Diabetes fact sheet. Sheet number 312. November 2009. Available at: http://www.who.int/mediacentre/fact sheets/fs312/en/. Accessed March 29, 2010.
9. Huang ES, Brown SE, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30:2478-2483. (Pubitemid 47547775)
10. Fried TR, McGraw S, Agostini JV, et al. Views of older persons with multiple morbidities on competing outcomes and clinical decisionmaking. J Am Geriatr Soc. 2008;56:1839-1844.
11. Struijs JN, Baan CA, Schellevis FG, et al. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6:84.
12. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834. (Pubitemid 33051266)
13. Smith SM, Soubhi H, Fortin M, et al. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2012;4:CD006560.
14. Eton DT, Ramalho de Oliveira D, Egginton JS, et al. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas. 2012;3:39-49.
15. Heisler M, Bouknight RR, Hayward RA, et al. The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med. 2002;17:243-252. (Pubitemid 34415682)
16. Weiner SJ, Schwartz A, Sharma G, et al. Patient-centered decision making and health care outcomes: an observational study. Ann Intern Med. 2013;158:573-579.
17. The National Academies Press. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: The National Academies Press; 2001.
18. Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition - multimorbidity. JAMA. 2012;307:2493-2494.
19. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719-725.
20. Institute of Medicine. Current Best Practices and Proposed Standards for Development of Trustworthy CPG's: Part 1, Getting Started. In: Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, eds. Clinical Practice Guidelines We Can Trust. Chapter 4. Washington, DC: The National Academies Press; 2011:84-86. http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx.
21. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' Guides to the medical literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA. 2000;284:1290-1296.
22. Murad MH, Montori VM, Guyatt GH. Incorporating patient preferences in evidence-based medicine. JAMA. 2008;300:2483; author reply 2483-2484.
23. The AGREE Collaboration. Appraisal of Guidelines Research & Evaluation. September 2001. Available at: http://www.agreecollaboration.org/pdf/ agreeinstrumentfinal.pdf. Accessed March 30, 2010.
24. Garces JPD, Lopez GJP, Wang Z, et al. Eliciting patient perspective in patient-centered outcomes research: a meta narrative systematic review. Patient-Centered Outcomes Research Institute, 2012. Available at: http://www.pcori.org/assets/Eliciting-Patient-Perspective-in-Patient-Centered- Outcomes-Research-A-Meta-Narrative-Systematic-Review.pdf. Accessed March 23, 2013.
25. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
26. Alsafadi H, Morrissey J, Patel V. The updated Alphabet Strategy: facilitating the implementation of NICE guidelines. Diabetes Prim Care. 2009;11:148-160.
27. American Diabetes Association (ADA). Standards of medical care in diabetes - 2012. Diabetes Care. 2012;35(suppl 1):S11-S63.
28. American Diabetes Association (ADA). Diabetes management in correctional institutions. Diabetes Care. 2010;33(suppl 1):S75-S81.
29. Department of Veteran Affairs, Department of Defense (VA/DoD). Clinical Practice Guideline for the Management of Diabetes Mellitus. Washington, DC: Department of Veteran Affairs, Department of Defense http://www.healthquality. va.gov/diabetes/DM2010-FUL-v4e.pdf; 2010.
30. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31(suppl 1): S61-S78.
31. Bruno G, De Micheli A, Frontoni S, et al. Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". Nutr Metab Cardiovasc Dis. 2011;21:302-314.
32. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(suppl 2):1-53.
33. IDF Clinical Guidelines Task Force (IDFCGT Force). Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006;23:579-593.
34. Jellinger PS, Davidson JA, Blonde L, et al. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Endocr Pract. 2007;13:260-268.
35. Guzman JR, Lyra R, Aguilar-Salinas CA, et al. Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association. Rev Panam Salud Publica. 2010;28:463-471.
36. Ko SH, Kim SR, Kim DJ, et al. 2011 clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J. 2011;35:431-436.
37. Leszczyszyn-Pynka M, Pynka S. Management of the blood glucose abnormalities in HIV-infected Patients. HIV AIDS Rev. 2006;5:25-27. (Pubitemid 46938877)
38. Amod A, Ascott-Evans B, Berg G, et al. The 2012 SEMDSA guideline for the management of type 2 diabetes. J Endocrinol Metab Diabetes S Afr. 2012;17:S1-S95.
39. Matthaei S, Bierwirth R, Fritsche A, et al. Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes. 2009;117:522-557.
40. Maynard G, Wesorick DH, O'Malley C, et al. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med. 2008;3(suppl):29-41.
41. Michigan Quality Improvement Consortium (MQIC). Management of Diabetes Mellitus, 2010. Available at: http://www.med.umich.edu/1info/fhp/practiceguides/ diabetes/mqic.diabetes.pdf. Accessed June 4, 2011.
42. Wisconsin Diabetes Prevention and Control Program (Wisconsin DPCP). Wisconsin Diabetes Mellitus Essential Care Guidelines. Madison, WI: Department of Health Services. http://www.dhs.wisconsin. gov/publications/P4/P49356.pdf; 2012.
43. Joslin Diabetes Center and Joslin Clinic (JDC). Guideline for the care of the older adult with diabetes. 2007. Available at: http://www.joslin.org/docs/ Guideline-For-Care-Of-Older-Adults-with-Diabetes.pdf. Accessed June 4, 2011.
44. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963-1972. (Pubitemid 44156663)
45. National Institute for Health and Clinical Excellence (NIHCE). Type 2 diabetes: the management of type 2 diabetes. NICE clinical guidelines. 2009. Available at: http://publications.nice.org.uk/type-2-diabetes-cg87. Accessed October 5, 2012.
46. Qaseem A, Humphrey LL, Sweet DE, et al. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156: 218-231.
47. Riethof M, Flavin P, Lindvall B, et al. Diagnosis and Management of Type 2 Diabetes Mellitus in Adults. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI); 2012. https://www.icsi.org/-asset/3rrm36/Diabetes- Interactive0412.pdf.
48. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009;15:540-559.
49. Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: full text. Eur Heart J Suppl. 2007;9(suppl C):C3-C74.
50. Scottish Intercollegiate Guidelines Network (SIGN). Management of diabetes. A national clinical guideline. 2010. Available at: http://guideline.gov/content.aspx?id=16394. Accessed October 5, 2012.
51. Sigal RJ, Kenny GP, Wasserman DH, et al. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:1433-1438. (Pubitemid 44125954)
52. Menendez Torre E, Lafita Tejedor J, Artola Menendez S, et al. Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document. Nefrologia. 2011;31:17-26.
53. Vijan S, Ci Choe H, Funnell MM, et al. University of Michigan Health System Type 2 Diabetes Guideline Update. 2009. Available at: http://cme.med.umich.edu/pdf/guideline/dm08.pdf.
54. Mutasingwa DR, Ge H, Upshur RE. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician. 2011;57:e253-e262.
55. Braithwaite RS, Concato J, Chang CC, et al. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007;167:2361-2365. (Pubitemid 350179532)
56. Fitzgerald SP, Bean NG. An analysis of the interactions between individual comorbidities and their treatments - implications for guidelines and polypharmacy. J Am Med Dir Assoc. 2010;11:475-484.
57. van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet. 2006;367:550-551. (Pubitemid 43247552)
58. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society. J Am Geriatr Soc. 2012;60:1957-1968.
59. Lipska KJ, Montori VM. Glucose control in older adults with diabetes mellitus-more harm than good?: comment on "The association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus". JAMA Intern Med. 2013;10:1-2.
60. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719-725.
61. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725-731. (Pubitemid 44115387)
62. Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008;337:a744.
63. Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012;344:e256.
64. Weiner SJ, Schwartz A, Weaver F, et al. Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med. 2010;153:69-75.